Pediarix pentavalent vaccine regulatory update

The FDA approved for marketing GSK's Pediarix pentavalent vaccine to prevent diphtheria, tetanus, pertussis, hepatitis B, and polio in infants. The vaccine, which is dosed at 2, 4, and 6 months of age...